|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/14/20 Escalon Medical Corp 10-Q 12/31/19 51:4.4M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 372K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 18K
45: R1 Document And Entity Information HTML 44K
31: R2 Consolidated Balance Sheets HTML 116K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
40: R4 Consolidated Statements Of Operations HTML 87K
46: R5 Consolidated Statements Of Shareholders' Equity HTML 49K
and Comprehensive Loss
32: R6 Consolidated Statements Of Cash Flows HTML 94K
16: R7 Organization and Description of Business HTML 22K
41: R8 Going concern (Notes) HTML 22K
44: R9 Significant Accounting Policies HTML 139K
36: R10 Discontinued operation (Notes) HTML 56K
48: R11 Related Party Transactions HTML 27K
26: R12 Line of credit (Notes) HTML 24K
20: R13 Concentration of credit risk (Notes) HTML 47K
35: R14 Retirement and post retirement plans (Notes) HTML 22K
47: R15 Significant Accounting Policies (Policies) HTML 258K
25: R16 Leases (Policies) HTML 88K
19: R17 Significant Accounting Policies (Tables) HTML 115K
34: R18 Concentration of credit risk (Tables) HTML 50K
49: R19 Retirement and post retirement plans (Tables) HTML 19K
28: R20 Inventories (Tables) HTML 40K
14: R21 Leases (Tables) HTML 135K
39: R22 Going concern (Details) HTML 19K
43: R23 Significant Accounting Policies (Cash and Cash HTML 21K
Equivalents) (Details)
27: R24 Significant Accounting Policies (Inventory) HTML 28K
(Details)
13: R25 Significant Accounting Policies (Accounts HTML 18K
Receivable) (Details)
38: R26 Significant Accounting Policies (Net Income (loss) HTML 32K
Per Share) (Details)
42: R27 Significant Accounting Policies Earning per share HTML 65K
details (Details)
29: R28 Significant Accounting Policies Goodwill and HTML 18K
intangible assets (Details)
12: R29 Significant Accounting Policies deferred revenue HTML 23K
(Details)
17: R30 Discontinued operation (Details) HTML 37K
23: R31 Related Party Transactions (Details) HTML 46K
50: R32 Line of credit (Details) HTML 56K
37: R33 Concentration of credit risk (Details) HTML 89K
18: R34 Revenue from contracts with customers (Details) HTML 23K
24: R35 Retirement and post retirement plans (Details) HTML 31K
51: R36 Leases (Details) HTML 64K
30: R9999 Uncategorized Items - esmc-20191231.xml HTML 20K
21: XML IDEA XML File -- Filing Summary XML 85K
22: EXCEL IDEA Workbook of Financial Reports XLSX 53K
6: EX-101.INS XBRL Instance -- esmc-20191231 XML 1.19M
8: EX-101.CAL XBRL Calculations -- esmc-20191231_cal XML 126K
9: EX-101.DEF XBRL Definitions -- esmc-20191231_def XML 399K
10: EX-101.LAB XBRL Labels -- esmc-20191231_lab XML 945K
11: EX-101.PRE XBRL Presentations -- esmc-20191231_pre XML 576K
7: EX-101.SCH XBRL Schema -- esmc-20191231 XSD 88K
33: ZIP XBRL Zipped Folder -- 0000862668-20-000002-xbrl Zip 142K
| Exhibit |
1. | I have reviewed this annual report on Form 10-Q of Escalon Medical Corp.; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Mark
Wallace | |
Date: February 14, 2020 | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/14/20 | None on these Dates | ||
| For Period end: | 12/31/19 | |||
| List all Filings | ||||